Refine by
Paralysis Articles & Analysis: Older
36 news found
Degeneration of these neurons leads to paralysis as the brain loses its ability to control muscle movement. Most people with ALS succumb to respiratory failure, usually within three to five years from when symptoms first appear. ...
Stroke may result in severely restricted movement, paralysis, loss of speech or vision, which may be permanent, or even death. ...
ByBayer AG
“The first-in-human implant of an endovascular BCI in the U.S. is a major clinical milestone that opens up new possibilities for patients with paralysis,” said Tom Oxley, MD, PhD, CEO & Founder, Synchron. ...
“I am honored and excited to join the Synchron team and be part of this amazing journey to help the millions of people worldwide who suffer from paralysis,” said Kurt Haggstrom, Chief Commercial Officer, Synchron. ...
The system is designed for patients suffering from paralysis as a result of a broad range of conditions, and aims to be user friendly and dependable for patients to use autonomously. ...
Cataplexy is characterized by sudden and uncontrolled muscle weakness or paralysis. Pitolisant has an orphan designation in the EU and the US for the treatment of narcolepsy. ...
Synchron and Mount Sinai Hospital in New York Advance Industry-First FDA-Approved Clinical Trial for Brain-Computer Interface in U.S. Paralysis is a devastating condition for more than 5 million patients in the United States Synchron, an endovascular brain-computer (BCI) interface company, today announced the enrollment of the first patient in the US clinical trial, ...
“Years of research and technological development culminated in this moment, and as we continue to develop our technology, it has the potential to change the lives of millions of patients globally who suffer from paralysis and other debilitating neurological and brain-related ...
“I’m both honored and thrilled to work with Edward, Max, Jordi and Earl, who will play an invaluable role in guiding our strategic decisions as we advance our endovascular brain computer interface to treat individuals with a significant unmet medical need, beginning with patients with severe paralysis.” Synchron has developed an endovascular brain computer ...
Philip received the endovascular Stentrode brain computer interface in April 2020 following progressive paralysis caused by ALS which left him unable to engage in work-related or other independent activities. ...
There are an estimated 5.35 million1 people in the United States who suffer from paralysis due to central nervous system disorders, autoimmune diseases, and spinal cord injuries. ...
These include two cell therapies - one for skin rejuvenation and one for tendon regeneration - and a next-generation dermal injector (DermaPrecise™) for aesthetic treatments involving a wide variety of injectable substances including cells, PRP, muscle paralysis toxins, fillers, enzymes, drugs, and other biologics. RepliCel’s cell therapy technology is the subject of ...
Compared with traditional practice that relies on the manual sense, EpiFaith® provides intuitive signal that tells anesthesiologists the arrival of epidural space, thus prevent the accidental puncture to dura, avoiding the risk of serious headache, paralysis, prolonged admission time, and related healthcare costs. “Post-dural puncture headache is a complication which ...
Our first target is the motor cortex for treatment of paralysis, which represents a large unmet need for millions of people across the world, and market opportunity of ...
These include two cell therapies - one for skin rejuvenation and one for tendon regeneration - and a next-generation dermal injector for aesthetic treatments involving a wide variety of injectable substances including cells, PRP, muscle paralysis toxins, fillers, enzymes, drugs, other biologics, etc. The RepliCel cell therapy technology which is the subject of active, ongoing ...
Inadvertent nerve injury during surgical procedures can cause significant morbidity including numbness, paralysis, urinary incontinence and erectile dysfunction, depending on the clinical setting. ...
Approximately 800,000 American adults experience a stroke each year, of which approximately 300,000 are left with upper extremity movement dysfunction. Muscular weakness or partial paralysis frequently persists into the chronic stage of stroke with 65% of chronic stroke patients reporting reduced motor function six months after stroke. ...
Although stroke is a brain disease, it can affect the entire body and sometimes causes long-term disability such as complete paralysis of one side of the body (hemiplegia) or one-sided weakness (hemiparesis) of the body. ...
Neuraptive plans to conduct a Phase 2 Multicenter, Randomized, Controlled Study Evaluating the Safety and Efficacy of NTX-001 versus Standard of Care in Treatment and Prevention of Facial Paralysis Requiring Surgical Repair. Neuraptive Therapeutics, Inc. ...
The most common symptoms of NMOSD are optic neuritis, which can cause visual problems including blindness, and transverse myelitis, which can cause mobility problems including paralysis. The disease primarily affects women, with an average age of onset of 39 years. ...